Cadence Pharmaceuticals™

Press Releases

 
All Releases
View Summary Cadence Pharmaceuticals Announces FDA Extends New Drug Application Review for Intravenous Acetaminophen by Three Months
Nov 13, 2009
PDF 14.2 KB
View Summary Cadence Pharmaceuticals Reports Third Quarter 2009 Financial Results
Nov 5, 2009
PDF 17.8 KB
View Summary Cadence Pharmaceuticals to Host Conference Call and Webcast to Discuss Third Quarter 2009 Financial Results on November 5, 2009
Oct 29, 2009
PDF 9.5 KB
View Summary Cadence Pharmaceuticals' CEO Ted Schroeder To Present at the Oppenheimer 20th Annual Healthcare Conference in New York City on November 4, 2009
Oct 28, 2009
PDF 9.3 KB
View Summary Cadence Pharmaceuticals' CEO Ted Schroeder to Present at the BIOCOM Investor Conference in San Diego on October 27, 2009
Oct 20, 2009
PDF 9.3 KB
View Summary Cadence Pharmaceuticals to Webcast October 7th Analyst Day
Sep 30, 2009
PDF 13.4 KB
View Summary Cadence Pharmaceuticals' CEO Ted Schroeder to Present at the JMP Securities Healthcare Focus Conference in New York on October 6, 2009
Sep 29, 2009
PDF 9.3 KB
View Summary Cadence Pharmaceuticals to Present at Two Investment Conferences During the Month of September 2009
Sep 9, 2009
PDF 9.7 KB
View Summary Cadence Pharmaceuticals Reports Second Quarter 2009 Financial Results
Aug 5, 2009
PDF 17.5 KB
View Summary Cadence Pharmaceuticals' CEO Theodore Schroeder to Present at the Canaccord Adams Global Growth Conference in Boston on August 11, 2009
Aug 4, 2009
PDF 9.1 KB
View Summary Cadence Pharmaceuticals to Host Conference Call and Webcast to Discuss Second Quarter 2009 Financial Results on August 5, 2009
Jul 29, 2009
PDF 9.3 KB
View Summary Cadence Pharmaceuticals Announces Priority Review and Acceptance of NDA Submission for Acetavance(TM) for Treatment of Acute Pain and Fever
Jul 15, 2009
PDF 13.4 KB
View Summary Cadence Pharmaceuticals Announces Appointment of Scott Byrd as Chief Commercial Officer
Jun 22, 2009
PDF 12.1 KB
View Summary Cadence Pharmaceuticals' CEO Theodore Schroeder to Present at the Needham Life Sciences Conference in New York on June 11, 2009
Jun 4, 2009
PDF 9.8 KB
View Summary Cadence Pharmaceuticals Submits Acetavance New Drug Application for the Treatment of Acute Pain and Fever
May 14, 2009
PDF 13.9 KB
View Summary Cadence Pharmaceuticals Reports First Quarter 2009 Financial Results
May 7, 2009
PDF 16.1 KB
View Summary Cadence Pharmaceuticals' CEO Ted Schroeder to Present at Two Investment Conferences During the Month of May 2009
May 5, 2009
PDF 10.0 KB
View Summary Cadence Pharmaceuticals to Host Conference Call and Webcast to Discuss First Quarter 2009 Financial Results on May 7, 2009
Apr 30, 2009
PDF 9.6 KB
View Summary Cadence Pharmaceuticals Announces Presentations at Upcoming Scientific Conferences
Apr 27, 2009
PDF 10.6 KB
View Summary Cadence Pharmaceuticals' CEO Theodore Schroeder to Present at BioCentury Publications Inc. Future Leaders in the Biotech Industry Conference in New York on April 2, 2009
Mar 26, 2009
PDF 9.8 KB
Showing 1-20 of 97 releases Page: 1 2 3 4 5  See Next 20
Print page Print
Email page Email


Stock Quote
CADX - (NASDAQ)
$10.34   + 0.45
Feb 9, 2010
3:59 PM ET

Quotes delayed at
least 20 minutes.
Information provided
by eSignal.